Exousia Bio, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $51.4K | $-25.8K | $-56.4K |
| Depreciation & Amortization | — | — | — |
| Depreciation | $3.8K | $5.0K | $5.0K |
| Amortization | — | — | — |
| Stock-Based Compensation | — | — | — |
| Net Cash from Operating Activities | $-4.5K | $-12.5K | $-38.1K |
| Investing Activities | |||
| Capital Expenditures | — | — | — |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $0 | $0 | $0 |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $3.5K | $5.7K | $35.9K |
| Net Change in Cash | — | — | — |
| Free Cash Flow | — | — | — |